Team Careers Products Medical Affairs News Contact

Team Careers Products Medical Affairs News Contact

Back

Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients

March 18, 2021

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

Team Careers Products Medical Affairs - Report Adverse Events - Report Product Complaints News Contact

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

© 2025 INNOVIVA SPECIALTY THERAPEUTICS | ALL RIGHTS RESERVED